TCS Recognized as a Leader in IDC MarketScape for Life Science R&D Decentralized Clinical Trials Technology Solutions

Tata Consultancy Services’ End-To-End Offering for Decentralized Trials, TCS ADD™ Connected Clinical Trials Cited as a Key Strength

PRESS RELEASE

NEW YORK | MUMBAI, October 25, 2022: Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS) has been named a Leader in the IDC MarketScape for Worldwide Life Science R&D Decentralized Clinical Trial (DCT) Technology Solutions^{^[1]}.

According to the report, “TCS' differentiators include the breadth of DCT capabilities that it offers, the ease of implementation of its solutions, and its competitive pricing. Its value proposition for DCTs is its end-to-end integrated platform and its ecosystem play.”

“The momentum towards adoption of digitalization of clinical trials has really accelerated in the past few years. We had however envisioned the shift towards decentralization in the clinical trials space early on and architected our solution accordingly. Consequently, when the pandemic hit, our customers were equipped to run studies leveraging our ready-to-use offerings such as eConsenting, Supply Management, smart medication management, BYOD configured patient and site app,” said Rachna Malik, Global Head, TCS ADD™ platforms. “We believe our position as a Leader in the evaluation of DCT providers validates the rectitude in our vision, investment in intellectual property and resulting market success.”

TCS ADD Connected Clinical Trials is a comprehensive suite of AI/ML-based platforms for decentralized trials. It provides a unified interface for patients and sites, facilitates collaboration with stakeholders such as regulators, sites, and health authorities, and enables patient-centric trials. The platform connects patients, sites, and sponsors through a variety of innovative sensors, smart medication packages, and mobile devices, to enhance trial outcomes. It caters to operations across the clinical studies lifecycle including e-consent, smart questionnaire (eCOA, diaries and surveys), an industry first supply management platform that brings together kit tracking, digital labels, and unit/dose tracking (medication adherence), and telemedicine.

The platform is comprehensive, interoperable and supports eco-system interplay, has multilingual capabilities, as well as the ability to be hosted on multi-cloud and multi-region. In addition, TCS ADD Connected Clinical Trials supports automated data collection, enables remote monitoring and oversight suitable for high frequency and a high volume of data.

“The DCT landscape is an ever-evolving ecosystem play, including a multitude of players bringing together a wide spectrum of innovative technologies. The secret sauce for scaling success will lie in integrating the right mix of partners and technologies, harmonizing workflows and dataflows, and building ‘digital-first’ strategies to provide patients and sites with an enriched, frictionless experience, while ensuring compliance at all costs,” said Dr Nimita Limaye, Research VP, Life Sciences R&D Strategy & Technology, IDC. “The TCS ADD suite of modern and open platforms, and TCS’ ability to drive cross-industry collaborations and expertise in technology implementation have made it a Leader in this report.”

About TCS ADD™ platforms

TCS ADD™ is a suite of modern and open drug development platform for life sciences that enables digital ecosystems, simplifies data complexity and provides faster access to new and effective drugs for patients in need. The platform is powered by our proprietary cognitive artificial intelligence engine, data driven smart analytics and Internet of Things (IoT) that makes clinical trials more agile and safe. TCS ADD leverages the best of cloud architecture and personalized user experience design in compliance with quality guidelines and privacy regulations.

To know more visit www.tcs.com/tcs-add or email: add.platform@tcs.com

About IDC MarketScape:

IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.

TCS media contacts

Corporate
Communications & India

corporate.communications@tcs.com

saxena.kritika@tcs.com

+91 22 6778 9999

vanshika.sood@tcs.com

+91 22 67789098

Asia Pacific

y.tham@tcs.com

+65 9720 9005

Canada

tiffany.fisher@tcs.com

+1 416 456 7650

Latin America

alma.leal@tcs.com

+521 55 2095 6098

Australia and New Zealand

kelly.ryan@tcs.com

+61 422 989 682

Europe

joost.galema@tcs.com

+31 615 903387

Japan

douglas.foote@tcs.com

+81 80 2115 0989

Middle East & Africa

pragya.priyadarshini@tcs.com

+971 528656700

UK

t.doherty@tcs.com

+44(0)7759396160

USA

james.sciales@tcs.com

+1 917 981 7651

Contact

TCS is here to make a difference through technology.

We’re in it for good, driving positive change for the benefit of all.

Extraordinary expertise leads to remarkable results.

Want to be a global change-maker? Join our team.

Find the latest news about TCS in our Newsroom

Recent Press releases

Recent News

Recent recognitions

Upcoming events

TCS works hand in hand with world-leading investors.